174 related articles for article (PubMed ID: 27075633)
1. Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
Sun S; Zheng XJ; Huo CX; Song C; Li Q; Ye XS
ChemMedChem; 2016 May; 11(10):1090-6. PubMed ID: 27075633
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and immunological evaluation of N-acyl modified Tn analogues as anticancer vaccine candidates.
Song C; Sun S; Huo CX; Li Q; Zheng XJ; Tai G; Zhou Y; Ye XS
Bioorg Med Chem; 2016 Feb; 24(4):915-20. PubMed ID: 26787275
[TBL] [Abstract][Full Text] [Related]
3. Fluorine-modified sialyl-Tn-CRM197 vaccine elicits a robust immune response.
Song C; Zheng XJ; Guo H; Cao Y; Zhang F; Li Q; Ye XS; Zhou Y
Glycoconj J; 2019 Oct; 36(5):399-408. PubMed ID: 31267246
[TBL] [Abstract][Full Text] [Related]
4. Synthetic and immunological studies of N-acyl modified S-linked STn derivatives as anticancer vaccine candidates.
Huo CX; Zheng XJ; Xiao A; Liu CC; Sun S; Lv Z; Ye XS
Org Biomol Chem; 2015 Mar; 13(12):3677-90. PubMed ID: 25679360
[TBL] [Abstract][Full Text] [Related]
5. Chemoenzymatic synthesis and immunological evaluation of sialyl-Thomsen-Friedenreich (sTF) antigen conjugate to CRM197.
Weng W; Ren S; Teng C; Guo J; Guo Q; Zhang W; Zong C; Ding N
Bioorg Med Chem; 2024 Feb; 100():117615. PubMed ID: 38342079
[TBL] [Abstract][Full Text] [Related]
6. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
Pecetta S; Tontini M; Faenzi E; Cioncada R; Proietti D; Seubert A; Nuti S; Berti F; Romano MR
Vaccine; 2016 Apr; 34(20):2334-41. PubMed ID: 27015733
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of the immunogenicity of synthetic carbohydrate vaccines by chemical modifications of STn antigen.
Yang F; Zheng XJ; Huo CX; Wang Y; Zhang Y; Ye XS
ACS Chem Biol; 2011 Mar; 6(3):252-9. PubMed ID: 21121644
[TBL] [Abstract][Full Text] [Related]
8. Direct targeted glycation of the free sulfhydryl group of cysteine residue (Cys-34) of BSA. Mapping of the glycation sites of the anti-tumor Thomsen-Friedenreich neoglycoconjugate vaccine prepared by Michael addition reaction.
Demian WL; Kottari N; Shiao TC; Randell E; Roy R; Banoub JH
J Mass Spectrom; 2014 Dec; 49(12):1223-33. PubMed ID: 25476939
[TBL] [Abstract][Full Text] [Related]
9. Carrier priming with CRM 197 or diphtheria toxoid has a different impact on the immunogenicity of the respective glycoconjugates: biophysical and immunochemical interpretation.
Pecetta S; Lo Surdo P; Tontini M; Proietti D; Zambonelli C; Bottomley MJ; Biagini M; Berti F; Costantino P; Romano MR;
Vaccine; 2015 Jan; 33(2):314-20. PubMed ID: 25448110
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Immunological Evaluation of Disaccharide Bearing MUC-1 Glycopeptide Conjugates with Virus-like Particles.
Wu X; McKay C; Pett C; Yu J; Schorlemer M; Ramadan S; Lang S; Behren S; Westerlind U; Finn MG; Huang X
ACS Chem Biol; 2019 Oct; 14(10):2176-2184. PubMed ID: 31498587
[TBL] [Abstract][Full Text] [Related]
11. [Recent advance in carbohydrate-based cancer vaccines].
Huo CX; Ye XS
Yao Xue Xue Bao; 2012 Mar; 47(3):261-70. PubMed ID: 22645748
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and immunological evaluation of the unnatural β-linked mucin-1 Thomsen-Friedenreich conjugate.
Wu X; McFall-Boegeman H; Rashidijahanabad Z; Liu K; Pett C; Yu J; Schorlemer M; Ramadan S; Behren S; Westerlind U; Huang X
Org Biomol Chem; 2021 Mar; 19(11):2448-2455. PubMed ID: 33645601
[TBL] [Abstract][Full Text] [Related]
13. Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccines.
Wu J; Guo Z
Bioconjug Chem; 2006; 17(6):1537-44. PubMed ID: 17105234
[TBL] [Abstract][Full Text] [Related]
14. Chemoselective assembly and immunological evaluation of multiepitopic glycoconjugates bearing clustered Tn antigen as synthetic anticancer vaccines.
Grigalevicius S; Chierici S; Renaudet O; Lo-Man R; Dériaud E; Leclerc C; Dumy P
Bioconjug Chem; 2005; 16(5):1149-59. PubMed ID: 16173792
[TBL] [Abstract][Full Text] [Related]
15. Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate.
Kleski KA; Trabbic KR; Shi M; Bourgault JP; Andreana PR
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183149
[TBL] [Abstract][Full Text] [Related]
16. Cancer Vaccines Based on Fluorine-Modified KH-1 Elicit Robust Immune Response.
Liu Y; Li B; Zheng X; Xiong D; Ye X
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838925
[TBL] [Abstract][Full Text] [Related]
17. The adjuvant effect of TLR7 agonist conjugated to a meningococcal serogroup C glycoconjugate vaccine.
Donadei A; Balocchi C; Mancini F; Proietti D; Gallorini S; O'Hagan DT; D'Oro U; Berti F; Baudner BC; Adamo R
Eur J Pharm Biopharm; 2016 Oct; 107():110-9. PubMed ID: 27388628
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.
Longenecker BM; Willans DJ; MacLean GD; Selvaraj S; Suresh MR; Noujaim AA
J Natl Cancer Inst; 1987 Mar; 78(3):489-96. PubMed ID: 3469463
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines.
Xiao A; Zheng XJ; Song C; Gui Y; Huo CX; Ye XS
Org Biomol Chem; 2016 Jul; 14(30):7226-37. PubMed ID: 27380866
[TBL] [Abstract][Full Text] [Related]
20. Postoperative change of anti-Thomsen-Friedenreich and Tn IgG level: the follow-up study of gastrointestinal cancer patients.
Smorodin EP; Kurtenkov OA; Sergeyev BL; Kodar KE; Chuzmarov VI; Afanasyev VP
World J Gastroenterol; 2008 Jul; 14(27):4352-8. PubMed ID: 18666325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
